Although systemic immunotherapy has achieved durable responses and improved survival
for certain patients and cancer types, low response rates and immune system-related …

Immunogenic cell death (ICD) is a special pattern of tumor cell death, enabling to elicit tumor‐
specific immune response via the release of damage‐associated molecular patterns and …

Cancer immunotherapy is a therapeutic strategy to inhibit tumor growth and metastasis by
intervening in the immune response process. Strategies applied to cancer immunotherapy …

Immunogenic cell death (ICD), a dying state of the cells, encompasses the changes in the
conformations of cell surface and the release of damage‐associated molecular patterns …

The emergence of precision medicine and personalized pharmacotherapy has led to the
development of advanced drug delivery systems that can respond to multiple stimuli …

Background Immunotherapy has emerged as an efficient therapeutic approach for cancer
management. However, stimulation of host immune system against cancer cells often fails to …

The successful treatment of oncological malignancies which results in long-term disease
control or the complete eradication of cancerous cells necessitates the onset of adaptive …

Abstract Development of effective nanomedicines to deal with tumor immunogenicity and
immunosuppression is vital to improve the immunotherapy efficacy. Herein, we developed a …

The field of oncology has transformed in recent years, with treatments shifting from
traditional surgical resection and radiation therapy to more diverse and customized …

水凝胶和纳米颗粒在药物递送方面具有极大的应用前景. 水凝胶具有良好的生物相容性以及物理
化学的多功能性, 可以实现疾病触发的原位自组装和药物持续性或响应性释放 …